Notable Wednesday Option Activity: STNG, COHR, A

Unusually large options activity was recorded in Coherent Corp (COHR) and Agilent Technologies (A), with COHR showing 16,037 contracts (~1.6 million underlying shares), about 41.7% of COHR's one‑month average daily volume (3.8M shares); the $210 call expiring Jan 16, 2026 accounted for 5,341 contracts (~534,100 shares). Agilent options volume totaled 8,284 contracts (~828,400 shares), roughly 40.7% of its one‑month average daily volume (2.0M shares), led by 5,733 contracts (~573,300 shares) in the $150 call expiring Sep 18, 2026. Such concentrated call activity suggests notable bullish positioning or large directional wagers that could affect short‑term volatility and order flow for both names.

Analysis

Market structure: Large, concentrated long-dated call prints in COHR (5,341 contracts at $210 Jan-16-2026) and A (5,733 contracts at $150 Sep-18-2026) imply one or a few institutional buyers seeking multi-quarter upside exposure; market-makers will delta-hedge, mechanically buying underlying on positive flows which can lift shares near-term. Winners are long-equity holders, options sellers collecting premium, and market-makers who capture spread; losers are naked put/short-equity positions that get squeezed. Expect a rise in implied volatility (IV) and tighter short interest in underlying ahead of key catalysts.

Risk assessment: Tail risks include sector-specific shocks (export controls for photonics/COHR; capex pullback or lab-budget cuts for Agilent), macro regime change (Fed surprise, >100bp shock) or a large seller unwinding long-dated calls causing IV collapse. Immediate (days) risk: delta-hedging-driven moves and IV spikes; short-term (weeks–months): earnings/Guidance and macro data; long-term (to 2026 expiries): product cycles and M&A. Hidden dependency: a single buyer using calls as a synthetic equity purchase or to hedge a larger cross-border transaction — flow is not pure directional signal.

Trade implications: For COHR (ticker COHR) consider a defined-risk bullish LEAPS structure: buy Jan-2026 $210 / $260 call debit spread (allocate 1–2% NAV) to capture upside while capping premium exposure; for Agilent (A) consider Sep-2026 $150 calendar or vertical call spreads (1–2% NAV). Pair trade: long A vs short DHR (Danaher) sized to neutralize beta over 6–12 months—target relative outperformance of 8–15% if instrument-specific demand persists. Use IV thresholds: avoid buying if target call IV >30% above 90-day mean; consider selling premium (iron condor) if IV >80th percentile.

Contrarian angles: The obvious bullish read may be overstated — large call prints can be part of collateralized strategies or risk reversals; if market-makers are net long delta, a small negative catalyst can force rapid deleveraging and a >15% drawdown in under a week. Historical parallels (post-earnings option accumulation ahead of M&A) show both big re-rates and painful IV collapses; plan for both by sizing positions small (1–3% NAV), using spreads, and setting objective exit triggers (e.g., realize gains at +40–60% or cut at -25%).

Key Decisions for Investors

• Establish a 1–2% NAV defined-risk bullish position in COHR via Jan-16-2026 $210/$260 call debit spreads (buy $210, sell $260) within the next 2 weeks; trim/close if COHR falls >25% from entry or if call IV compresses >30% from entry.
• Establish a 1–2% NAV bullish position in Agilent (A) using Sep-18-2026 $150 call spreads (or LEAPS + sell nearer-term puts) and target a 12-month horizon; exit or convert to stock if A outperforms peers by >15% or misses revenue guidance by >5%.
• Implement a relative-value pair: long A vs short DHR sized to neutralize market beta (6–12 month holding), target 8–15% relative return if instrument/sequencer demand remains strong; unwind if macro risk-off (S&P down >8% in 30 days).